[HTML] frontiersin.org

[HTML][HTML] Immunotherapy for pediatric acute lymphoblastic leukemia: Recent advances and future perspectives

M Lv, Y Liu, W Liu, Y Xing, S Zhang - Frontiers in Immunology, 2022 - frontiersin.org
Pediatric acute lymphoblastic leukemia (ALL) is the most common subtype of childhood
leukemia, which is characterized by the abnormal proliferation and accumulation of …
被引用次数：7 相关文章
[HTML] nih.gov

[HTML][HTML] Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives

M Lv, Y Liu, W Liu, Y Xing, S Zhang - Frontiers in Immunology, 2022 - ncbi.nlm.nih.gov
Pediatric acute lymphoblastic leukemia (ALL) is the most common subtype of childhood
leukemia, which is characterized by the abnormal proliferation and accumulation of …

Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives

M Lv, Y Liu, W Liu, Y Xing… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Pediatric acute lymphoblastic leukemia (ALL) is the most common subtype of childhood
leukemia, which is characterized by the abnormal proliferation and accumulation of …

Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives.

M Lv, Y Liu, W Liu, Y Xing, S Zhang - Frontiers in Immunology, 2022 - europepmc.org
Pediatric acute lymphoblastic leukemia (ALL) is the most common subtype of childhood
leukemia, which is characterized by the abnormal proliferation and accumulation of …